Table 3.
Comparison of antimicrobial therapies prescribed in the empirical and the rm-PCR-guided groups (n = 159)
| Antibiotic treatment | Routine empirical therapy (%) | rm-PCR-guided therapy (%) |
|---|---|---|
| Beta-lactams | 147 (92) | 131 (82) |
| Third-generation cephalosporin | 35 (22) | 24 (15) |
| Piperacillin-tazobactam | 29 (18) | 34 (21) |
| Amoxicillin-clavulanate | 27 (17) | 25 (16) |
| Carbapenem | 27 (17) | 19 (12) |
| Cefepime | 19 (12) | 19 (12) |
| Amoxicillin | 5 (3) | 4 (3) |
| Ceftazidime | 3 (2) | 7 (4) |
| Cefazolin | 2 (1) | 6 (4) |
| Penicillin M | 0 (0) | 2 (1) |
| Companion molecule | 79 (50) | 50 (31) |
| Macrolide | 20 (13) | 4 (3) |
| Metronidazole | 17 (11) | 8 (5) |
| Aminoglycoside | 15 (9) | 19 (12) |
| Fluoroquinolone | 8 (5) | 5 (3) |
| Glycopeptide | 6 (4) | 2 (1) |
| Linezolide | 6 (4) | 8 (5) |
| Cotrimoxazole | 7 (4) | 4 (3) |
| Antifungal therapy | 5 (3) | 4 (3) |
| Oseltamivir | 3 (2) | 0 |
| Other | 4 (3) | 0 |
Results are presented as n (%)